Jellynov
Develops an orally ingested, drug-free weight-management product for people managing overweight
Highlights
- New on EvolcAdded 2026-11-13
About Jellynov
Jellynov develops an orally ingested solution designed to expand in the stomach before meals, promote early satiety and pass through the gastrointestinal tract.
Its stated mission is to support people with overweight in long-term weight management. The company is based in Chatillon, France, and was founded in 2017.
Product: An orally ingested, drug-free solution intended to expand in the stomach and promote early satiety before meals.
Jobs at Jellynov
More health & medtech companies
JHM Holding
Ambulance and patient transport services for individuals in the Cher region and across FranceNew on EvolcJK Concept
Medical IT software for hospitals: drug prescription, clinical trial and blood-derivative traceability modules for healthcare staffNew on EvolcJmsap
Home care and meal delivery for seniors and dependent adults in Meurthe-et-Moselle, FranceNew on Evolcjnlf.fr
French-language neurology congress in Lille for health professionals and medical industry partners, 20-23 April 2027Jobergroup
Medical recruitment services connecting healthcare employers with dental, medical and paramedical professionals in FranceJuisci
Clinical evidence search and literature tools for clinicians and healthcare organizationsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
Content management
- WebnodeHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Site generatormeta generator
- Site generatormeta generator
- Site generatormeta generator
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.